• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西罗莫司治疗两名患有卡萨巴赫-梅里特现象的婴幼儿卡波西样血管内皮瘤

Sirolimus for Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon in Two Infants.

作者信息

Wang Yuan, Kong Liangliang, Sun Buhao, Cui Jie, Shen Weimin

机构信息

Department of Plastic Surgery, Children's Hospital of Nanjing Medical University, Nanjing, China.

出版信息

J Craniofac Surg. 2020 Jun;31(4):1074-1077. doi: 10.1097/SCS.0000000000006301.

DOI:10.1097/SCS.0000000000006301
PMID:32176003
Abstract

Kaposiform hemangioendothelioma is an aggressive vascular tumor with infiltrative growth that commonly occurs in infancy and is associated with a life-threatening consumptive coagulopathy, as well as Kasabach-Merritt phenomenon. Recently, promising results have shown that sirolimus had been successfully used to treat Kasabach-Merritt phenomenon without significant toxicity. However, the situation the authors encountered in treating infants was not so satisfactory. Here, the authors present 2 patients younger than 3 months with refractory Kaposiform hemangioendothelioma treated with sirolimus and experienced severe pneumonia. The outcomes suggest that it is necessary to keep an eye on any symptoms indicate the infection of respiratory tract and use the antibiotics in time. The 2 cases also remind us of the potential sign that indicate the recurrence of KMP, which refers to firmer lesion with deepen color, especially when it comes with complications.

摘要

卡波西型血管内皮瘤是一种具有浸润性生长的侵袭性血管肿瘤,常见于婴儿期,与危及生命的消耗性凝血病以及卡萨巴赫-梅里特现象相关。最近,有前景的结果表明西罗莫司已成功用于治疗卡萨巴赫-梅里特现象且无明显毒性。然而,作者在治疗婴儿时遇到的情况并不那么令人满意。在此,作者介绍2例3个月以下难治性卡波西型血管内皮瘤患儿,接受西罗莫司治疗后出现严重肺炎。结果表明,有必要留意任何提示呼吸道感染的症状并及时使用抗生素。这2例病例也提醒我们注意卡萨巴赫-梅里特现象复发的潜在迹象,即病变变硬且颜色加深,尤其是伴有并发症时。

相似文献

1
Sirolimus for Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon in Two Infants.西罗莫司治疗两名患有卡萨巴赫-梅里特现象的婴幼儿卡波西样血管内皮瘤
J Craniofac Surg. 2020 Jun;31(4):1074-1077. doi: 10.1097/SCS.0000000000006301.
2
Retroperitoneal kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon and obstructive jaundice: A retrospective series of 3 patients treated with sirolimus.腹膜后卡波西样血管内皮瘤合并卡萨巴赫-梅里特现象及梗阻性黄疸:3例接受西罗莫司治疗患者的回顾性系列研究
Pediatr Dermatol. 2020 Jul;37(4):677-680. doi: 10.1111/pde.14157. Epub 2020 Mar 24.
3
Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus.婴儿期伴有卡波西样血管内皮瘤病-卡斯特曼现象的 Kaposiform 血管内皮瘤:泼尼松龙、长春新碱联合西罗莫司治疗成功。
Pediatr Blood Cancer. 2018 Dec;65(12):e27305. doi: 10.1002/pbc.27305. Epub 2018 Aug 1.
4
Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study.西罗莫司治疗进行性卡波西样血管内皮瘤:一项多中心回顾性研究。
Int J Cancer. 2017 Aug 15;141(4):848-855. doi: 10.1002/ijc.30775. Epub 2017 May 26.
5
Sirolimus as initial therapy for kaposiform hemangioendothelioma and tufted angioma.西罗莫司作为卡波西样血管内皮瘤和簇状血管瘤的初始治疗方法。
Pediatr Dermatol. 2018 Sep;35(5):635-638. doi: 10.1111/pde.13600. Epub 2018 Jul 12.
6
Successful Everolimus Treatment of Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon: Clinical Efficacy and Adverse Effects of mTOR Inhibitor Therapy.依维莫司成功治疗伴卡萨巴赫-梅里特现象的卡波西样血管内皮瘤:mTOR抑制剂治疗的临床疗效和不良反应
J Pediatr Hematol Oncol. 2016 Nov;38(8):e322-e325. doi: 10.1097/MPH.0000000000000509.
7
Successful treatment of Kasabach-Merritt phenomenon arising from Kaposiform hemangioendothelioma by sirolimus.西罗莫司成功治疗卡波西样血管内皮瘤引起的卡萨巴赫-梅里特现象。
J Pediatr Hematol Oncol. 2015 Jan;37(1):72-3. doi: 10.1097/MPH.0000000000000068.
8
Low dose sirolimus treatment for refractory tufted angioma and congenital kaposiform hemangioendothelioma, both with Kasabach-Merritt phenomenon.低剂量西罗莫司治疗难治性簇状血管瘤和先天性卡波西样血管内皮瘤,二者均伴有卡萨巴赫-梅里特现象。
Pediatr Blood Cancer. 2019 Aug;66(8):e27810. doi: 10.1002/pbc.27810. Epub 2019 May 14.
9
Rapidly enlarging "bruise" on the back of an infant. Kaposiform hemangioendothelioma complicated by Kasabach-Merritt syndrome.婴儿背部迅速增大的“瘀伤”。卡波西样血管内皮瘤合并卡萨巴赫-梅里特综合征。
JAMA Dermatol. 2013 Nov;149(11):1337-8. doi: 10.1001/jamadermatol.2013.519.
10
Sirolimus Treatment of an Infant With Intrathoracic Kaposiform Hemangioendothelioma Complicated by Life-threatening Pleural and Pericardial Effusions.西罗莫司治疗一名患有胸腔内卡波西样血管内皮瘤并伴有危及生命的胸腔和心包积液的婴儿。
J Pediatr Hematol Oncol. 2020 Jan;42(1):74-78. doi: 10.1097/MPH.0000000000001268.

引用本文的文献

1
Sirolimus for vascular anomalies in the first year of life: a systematic review.婴儿期血管性疾病应用西罗莫司治疗:系统综述。
J Perinatol. 2024 Aug;44(8):1087-1097. doi: 10.1038/s41372-024-01868-9. Epub 2024 Jan 20.
2
Efficacy of transcatheter arterial chemoembolization combined with sirolimus for treating Kasabach-Merritt phenomenon in infants, a retrospective study.经导管动脉化疗栓塞联合西罗莫司治疗婴儿卡波西样血管内皮瘤现象的疗效:一项回顾性研究。
Ann Med. 2023 Dec;55(1):2196090. doi: 10.1080/07853890.2023.2196090.
3
Case report: Kaposi hemangioendothelioma of the right upper limb with the Kasabach-Merritt phenomenon: A potentially lethal diagnostic challenge.
病例报告:伴有卡萨巴赫-梅里特现象的右上肢卡波西血管内皮瘤:一项具有潜在致命性的诊断挑战。
Front Pediatr. 2022 Nov 1;10:995399. doi: 10.3389/fped.2022.995399. eCollection 2022.
4
Effective low-dose sirolimus regimen for kaposiform haemangioendothelioma with Kasabach-Merritt phenomenon in young infants.低剂量西罗莫司治疗方案对患有卡萨巴赫-梅里特现象的婴幼儿卡波西型血管内皮瘤有效。
Br J Clin Pharmacol. 2022 Jun;88(6):2769-2781. doi: 10.1111/bcp.15202. Epub 2022 Jan 18.
5
[Clinical features of Kasabach-Merritt syndrome: an analysis of 16 neonates].[卡萨巴赫-梅里特综合征的临床特征:16例新生儿分析]
Zhongguo Dang Dai Er Ke Za Zhi. 2021 Jul;23(7):696-701. doi: 10.7499/j.issn.1008-8830.2103146.